Efficacy of the START-Play Program for Infants With Neuromotor Disorders (START-Play)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02593825 |
Recruitment Status :
Active, not recruiting
First Posted : November 1, 2015
Results First Posted : September 1, 2020
Last Update Posted : September 1, 2020
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cerebral Palsy Developmental Delay Infant Development | Behavioral: START-Play intervention Behavioral: Business as usual | Not Applicable |
Setting: The research will take place in the homes of infants and their families in Pennsylvania, Delaware, Washington, and Virginia.
Sample: There will be approximately 140 infants with neuromotor disorders completing participation in this study, beginning at the age the age of 7 to 16 months, as well as their families and interventionists. Infants will have gross motor delays but be able to sit propped up for at least 3 seconds when they are recruited for participation.
Intervention: Sitting Together And Reaching To Play (START-Play) is an intervention for infants with motor dysfunction or delay in which physical therapists visit the child's home to target work on siting, reaching, and problem solving. The therapist visits the home twice weekly for 3 months. During these visits, therapists and families work together to provide intensive, individualized, daily activities to advance reaching and sitting through small increments of challenge and support for these skills, which then become the building blocks for motor-based problem solving. More specifically, the intervention focuses on self-initiated, goal-directed movements to build orientation and attention to objects, while learning basic relationships of cause and effect. Infants and families in the intervention group will receive this intervention in addition to their usual early intervention services.
Research Design and Methods: This study will use a randomized controlled trial in which infants and their families are randomly assigned to the intervention group (START-Play in addition to usual services) or control group (usual early intervention services), stratified by severity of neuromotor disorder. There will be six measurement sessions during the 12-week intervention period, following by assessments during 1-, 3-, and 9-month follow-up visits. The study aims to determine the efficacy of the intervention on sitting and reaching (proximal outcomes) and motor-based problem solving skills (longer-term proximal outcome), which is hypothesized to serve as mediators to the more distal outcomes of global cognitive development and readiness to learn. The investigators will also explore fidelity of implementation to identify conditions that support fidelity and outcomes, as well as identify other moderating factors related to the child (severity of disorder, health, age, cognitive skill at entry), family (socioeconomic status, home environment), or services (fidelity of implementation, other services provided to child) to explore change over time.
Control Condition: Infants and their families in the control condition will continue to receive their regular Part C early intervention services.
Key Measures: Primary outcome measures in the study include the Gross Motor Function Measure and an observational measure of toy contacts for sitting and reaching, and the Individual and Growth Development Indicators (Early Problem Solving Indicator) and Bayley Scales of Infant and Toddler Development -Third Edition for problem solving and global development. Secondary measures include additional measures of postural control and reaching, child and family characteristics, and fidelity of implementation (logs and checklist).
Data Analytic Strategy: The investigators will use linear mixed modeling (LMM) to determine the efficacy of the intervention on child outcomes. Parallel process growth modeling within a structural equation modeling framework will be used to examine whether improvements in sitting and reaching are mediators leading to improvements in problem solving, which is then a mediator leading to long-term global cognitive development. LMM will also be used to examine moderating variables, as well as secondary motor outcomes.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 134 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Efficacy of the START-Play Program for Infants With Neuromotor Disorders |
Actual Study Start Date : | January 2016 |
Actual Primary Completion Date : | June 1, 2020 |
Estimated Study Completion Date : | July 1, 2022 |
Arm | Intervention/treatment |
---|---|
Experimental: START-Play intervention
Intervention incorporating cognitive factors and focusing on self-initiated movement toward achievement of skill in sitting and reaching to increase problem-solving skills, which will then improve overall developmental outcomes. Visits to home by physical therapist twice weekly with parent training, for 3 months.
|
Behavioral: START-Play intervention
The START-Play group is a perceptual-motor approach, which uses self-initiated goal-directed movements to bolster orienting and attending to objects, while understanding basic relationships of cause and effect through manipulation and focused attention. Generally, activities focus on helping the child attend to significant environmental information, which can be correlated to forces useful for controlling posture and movement. Unlike passive movement therapy, the investigator's approach encourages activity and learning to solve problems linked by movement and manipulation of objects, which then scaffold cognitive skill.
Other Name: Perceptual motor early intervention for infants |
Active Comparator: Business as Usual
Early motor intervention provided as standard treatment in the home for infants with motor dysfunction who are just beginning to sit. Dosage and content of intervention may vary from infant to infant and geographically.
|
Behavioral: Business as usual
May include active or passive movement, parent training, positioning, equipment modification, training other team members, functional skill training
Other Name: Early intervention, physical therapy |
- Bayley Scales of Infant Development III [ Time Frame: Baseline, at end of 3 month intervention, and at 12 months post-baseline ]Bayley Scales of Infant Development III, cognitive scale; raw scores used to reflect change over time and absolute growth (rather than standard scores) Range: Minimum =20 points; Maximum=60 Higher score = better outcome
- Change in Modified Parent Child Interaction-Dyadic Mini Code [ Time Frame: Baseline, at end of 3 month intervention, and at 6 and 12 months after baseline ]Play and interaction of parent and child, coding of behavior frequency and type of interaction
- Change in Postural Measure of Trunk Angles [ Time Frame: Baseline, at end of 3 month intervention, and at 6 and 12 months after baseline ]kinematic measure of pelvic and trunk sagittal angle in sitting
- Change in Frequency (Number) of Toy Contacts [ Time Frame: Baseline, at end of 3 month intervention, and at 12 months after baseline ]behavioral coding of play and hand use, coded from videotape; Coding software used to time contacts during standard reaching task during 5 minute reaching at shoulder level and below.
- Change in Duration (Time) of Toy Contacts [ Time Frame: Baseline, at end of 3 month intervention, and at 12 months after baseline ]coding number seconds of videotaped hand use during play; timing coded in a video coding software for behavioral analysis Higher score=better
- Change in Gross Motor Function Measure, Sitting Subscale [ Time Frame: Baseline, at end of 3 month intervention, and at 12 months after baseline ]Gross motor skills in the sitting subsection of the Gross Motor Function Measure (GMFM) Minimum value=4 Maximum value=60 Higher scores=better outcome
- Change in Early Problem Solving Indicator (EPSI) [ Time Frame: Baseline, at end of 3 month intervention, and at 6 and 12 months after baseline ]Infant growth and development indicator of problem solving skills, adapted for children with motor deficits Modified to Assessment of Problem-Solving in Play (APSP) Minimum=30 Maximum=120 Higher=better outcome
- Change in Reaching (Change in Duration and Hand of Toy Contacts) [ Time Frame: Baseline, at end of 3 month intervention, and at 12 months after baseline ]Time of toy contacts, whether reach is one or two handed, higher number is better outcome, will indicate bilateral or unilateral

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 7 Months to 16 Months (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
-
• Infants enter study between 7-16 months of age, when they are able to prop sit for 3 seconds and maintain their head at least to the level of neutral alignment with their trunk.
- Gross motor delay as reflected in the Bayley III motor subtest >1.0 Standard Deviation below the mean.
- Neuromotor disorder such as cerebral palsy (CP), or at risk for CP because of extreme prematurity or brain damage that occurred at or around birth, or infants with motor delay of an unspecified origin (no clear diagnosis, but delay as above) -• Minimal movement requirements/Indicators of readiness for change: Sits with support of arms for 3 seconds after being placed. Exhibits at least some spontaneous movement of arms.
Exclusion Criteria:
-
• Medical complications that severely limit participation in assessments and intervention such as severe visual and congenital/genetic anomalies, uncontrolled seizure disorder.
- Diagnosis other than an unchanging neuromotor disorder (examples: autism, Down syndrome, spinal cord injury, acquired head injury, muscle disorder).
- A child will be excluded if the parents report any of following: 1) if the child has a disability of a progressive nature such as muscular dystrophy; 2) if the child's family plans to move out of the local area within one year from the start of the study; 3) if the child has major surgery planned that might affect physical performance.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02593825
United States, Pennsylvania | |
Duquesne University | |
Pittsburgh, Pennsylvania, United States, 15282 |
Principal Investigator: | Regina T Harbourne, PhD | Duquesne University | |
Principal Investigator: | Sarah W McCoy, PhD | University of Washington | |
Principal Investigator: | Michele A. Lobo, PhD | University of Delaware | |
Principal Investigator: | Stacey C. Dusing, PhD | Virginia Commonwealth University |
Documents provided by Duquesne University:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Duquesne University |
ClinicalTrials.gov Identifier: | NCT02593825 |
Other Study ID Numbers: |
R324A150103 |
First Posted: | November 1, 2015 Key Record Dates |
Results First Posted: | September 1, 2020 |
Last Update Posted: | September 1, 2020 |
Last Verified: | July 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Cerebral Palsy Brain Damage, Chronic Brain Diseases Central Nervous System Diseases Nervous System Diseases |